Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|April 26, 2025
The soluble guanylate cyclase (sGC) stimulator vericiguat inhibits platelet activation and thrombosisWenxuan Zhou, Luning Zhou, Zhiyong Qi, et al.
Life Metabolism|March 13, 2025
Intermittent fasting inhibits platelet activation and thrombosis through the intestinal metabolite indole-3-propionateZhiyong Qi, Luning Zhou, Shimo Dai, et al.
Circulation Research|March 31, 2023
IL-37 Attenuates Platelet Activation and Thrombosis Through IL-1R8 PathwayYufei Chen, Jin Hong, Haoxuan Zhong, et al.
Blood|September 25, 2025
USP25-Mediated Talin-1 Stabilization in Platelets: A Novel Mechanism of Hyperreactivity and Thrombosis Risk During AgingXuemei Jia, Shuoyi Jiang, Hong Cheng, et al.
Blood|October 8, 2024
GSDME-mediated pyroptosis contributes to chemotherapy-induced platelet hyperactivity and thrombotic potentialRuyi Xue, Min Li, Ge Zhang, et al.
Biochemical Pharmacology|December 20, 2025
IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signalingMaieryemu Waresi, Huili Zhou, Can Jiao, et al.
Biochemical Pharmacology|June 19, 2026
Exosome-mediated transfer of NOD2 from platelets to monocytes: a novel therapeutic target for atherosclerosisGuanxing Pan, Zhiyong Qi, Xiaowen Wu, et al.
Nature Cardiovascular Research|April 11, 2025
The gut microbiota-bile acid-TGR5 axis orchestrates platelet activation and atherothrombosisZhiyong Qi, Wei Zhang, Peng Zhang, et al.
JACC. Basic to Translational Science|July 10, 2026
Calcitriol Suppresses Platelet Activation and Thrombosis, Mitigating Cardiovascular Risks in Metabolic Dysfunction-Associated Steatotic Liver DiseasePeng Zhang, Huajie Xu, Shujing Wu, et al.
Clinical Cardiology|February 4, 2022
Cilostazol combined with P2Y<sub>12</sub> receptor inhibitors: A substitute antiplatelet regimen for aspirin-intolerant patients undergoing percutaneous coronary stent implantationYikai Zhao, Peng Zhou, Wen Gao, et al.
Pageof 3